Two Novel Point Mutations in Clinical Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection


Staphylococcus aureus frequently invades the human bloodstream, leading to life threatening bacteremia and often secondary foci of infection. Failure of antibiotic therapy to eradicate infection is frequently described; in some cases associated with altered S. aureus antimicrobial resistance or the small colony variant (SCV) phenotype. Newer antimicrobials, such as linezolid, remain the last available therapy for some patients with multi-resistant S. aureus infections. Using comparative and functional genomics we investigated the molecular determinants of resistance and SCV formation in sequential S. aureus isolates from a patient who had a persistent and recurrent S. aureus infection, after failed therapy with multiple antimicrobials, including linezolid. Two point mutations in key staphylococcal genes dramatically affected clinical behaviour of the bacterium, altering virulence and antimicrobial resistance. Most strikingly, a single nucleotide substitution in relA (SACOL1689) reduced RelA hydrolase activity and caused accumulation of the intracellular signalling molecule guanosine 3′, 5′-bis(diphosphate) (ppGpp) and permanent activation of the stringent response, which has not previously been reported in S. aureus. Using the clinical isolate and a defined mutant with an identical relA mutation, we demonstrate for the first time the impact of an active stringent response in S. aureus, which was associated with reduced growth, and attenuated virulence in the Galleria mellonella model. In addition, a mutation in rlmN (SACOL1230), encoding a ribosomal methyltransferase that methylates 23S rRNA at position A2503, caused a reduction in linezolid susceptibility. These results reinforce the exquisite adaptability of S. aureus and show how subtle molecular changes cause major alterations in bacterial behaviour, as well as highlighting potential weaknesses of current antibiotic treatment regimens.


Vyšlo v časopise: Two Novel Point Mutations in Clinical Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000944
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000944

Souhrn

Staphylococcus aureus frequently invades the human bloodstream, leading to life threatening bacteremia and often secondary foci of infection. Failure of antibiotic therapy to eradicate infection is frequently described; in some cases associated with altered S. aureus antimicrobial resistance or the small colony variant (SCV) phenotype. Newer antimicrobials, such as linezolid, remain the last available therapy for some patients with multi-resistant S. aureus infections. Using comparative and functional genomics we investigated the molecular determinants of resistance and SCV formation in sequential S. aureus isolates from a patient who had a persistent and recurrent S. aureus infection, after failed therapy with multiple antimicrobials, including linezolid. Two point mutations in key staphylococcal genes dramatically affected clinical behaviour of the bacterium, altering virulence and antimicrobial resistance. Most strikingly, a single nucleotide substitution in relA (SACOL1689) reduced RelA hydrolase activity and caused accumulation of the intracellular signalling molecule guanosine 3′, 5′-bis(diphosphate) (ppGpp) and permanent activation of the stringent response, which has not previously been reported in S. aureus. Using the clinical isolate and a defined mutant with an identical relA mutation, we demonstrate for the first time the impact of an active stringent response in S. aureus, which was associated with reduced growth, and attenuated virulence in the Galleria mellonella model. In addition, a mutation in rlmN (SACOL1230), encoding a ribosomal methyltransferase that methylates 23S rRNA at position A2503, caused a reduction in linezolid susceptibility. These results reinforce the exquisite adaptability of S. aureus and show how subtle molecular changes cause major alterations in bacterial behaviour, as well as highlighting potential weaknesses of current antibiotic treatment regimens.


Zdroje

1. BishopEJ

HowdenBP

2007 Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions. Expert Opin Emerg Drugs 12 1 22

2. LowyFD

1998 Staphylococcus aureus infections. N Engl J Med 339 520 532

3. TurnidgeJD

KotsanasD

MunckhofW

RobertsS

BennettCM

2009 Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 191 368 373

4. MoisePA

ForrestA

BayerAS

XiongYQ

YeamanMR

2010 Factors Influencing Time to Vancomycin-Induced Clearance of Nonendocarditis Methicillin-Resistant Staphylococcus aureus Bacteremia: Role of Platelet Microbicidal Protein Killing and agr Genotypes. J Infect Dis 201 233 240

5. HowdenBP

DaviesJK

JohnsonPD

StinearTP

GraysonML

2010 Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: Resistance mechanisms, laboratory detection and clinical implications. Clin Microbiol Rev 23 99 139

6. SendiP

ProctorRA

2009 Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol 17 54 58

7. ProctorRA

von EiffC

KahlBC

BeckerK

McNamaraP

2006 Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 4 295 305

8. SeggewissJ

BeckerK

KotteO

EisenacherM

YazdiMR

2006 Reporter metabolite analysis of transcriptional profiles of a Staphylococcus aureus strain with normal phenotype and its isogenic hemB mutant displaying the small-colony-variant phenotype. J Bacteriol 188 7765 7777

9. von EiffC

BeckerK

MetzeD

LubritzG

HockmannJ

2001 Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier's disease. Clin Infect Dis 32 1643 1647

10. SchroderA

KlandR

PeschelA

von EiffC

AepfelbacherM

2006 Live cell imaging of phagosome maturation in Staphylococcus aureus infected human endothelial cells: small colony variants are able to survive in lysosomes. Med Microbiol Immunol 195 185 194

11. VaudauxP

FrancoisP

BisognanoC

KelleyWL

LewDP

2002 Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect Immun 70 5428 5437

12. TsujiBT

von EiffC

KelchlinPA

ForrestA

SmithPF

2008 Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype. Antimicrob Agents Chemother 52 1533 1537

13. SifriCD

Baresch-BernalA

CalderwoodSB

von EiffC

2006 Virulence of Staphylococcus aureus small colony variants in the Caenorhabditis elegans infection model. Infect Immun 74 1091 1096

14. GodfreyHP

BugryshevaJV

CabelloFC

2002 The role of the stringent response in the pathogenesis of bacterial infections. Trends Microbiol 10 349 351

15. MittenhuberG

2001 Comparative genomics and evolution of genes encoding bacterial (p)ppGpp synthetases/hydrolases (the Rel, RelA and SpoT proteins). J Mol Microbiol Biotechnol 3 585 600

16. MecholdU

MurphyH

BrownL

CashelM

2002 Intramolecular regulation of the opposing (p)ppGpp catalytic activities of Rel(Seq), the Rel/Spo enzyme from Streptococcus equisimilis. J Bacteriol 184 2878 2888

17. AbranchesJ

MartinezAR

KajfaszJK

ChavezV

GarsinDA

2009 The molecular alarmone (p)ppGpp mediates stress responses, vancomycin tolerance, and virulence in Enterococcus faecalis. J Bacteriol 191 2248 2256

18. PrimmTP

AndersenSJ

MizrahiV

AvarbockD

RubinH

2000 The stringent response of Mycobacterium tuberculosis is required for long-term survival. J Bacteriol 182 4889 4898

19. WolzC

GeigerT

GoerkeC

2009 The synthesis and function of the alarmone (p)ppGpp in firmicutes. Int J Med Microbiol 300 142 147

20. GeigerT

GoerkeC

FritzM

SchaferT

OhlsenK

2010 Role of the (p)ppGpp synthase RSH, a RelA/SpoT homolog, in stringent response and virulence of Staphylococcus aureus. Infect Immun 78 1873 1883

21. GentryD

LiT

RosenbergM

McDevittD

2000 The rel gene is essential for in vitro growth of Staphylococcus aureus. J Bacteriol 182 4995 4997

22. AndersonKL

RobertsC

DiszT

VonsteinV

HwangK

2006 Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover. J Bacteriol 188 6739 6756

23. MoisePA

NorthD

SteenbergenJN

SakoulasG

2009 Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect Dis 9 617 624

24. LeachKL

SwaneySM

ColcaJR

McDonaldWG

BlinnJR

2007 The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell 26 393 402

25. MekaVG

GoldHS

2004 Antimicrobial resistance to linezolid. Clin Infect Dis 39 1010 1015

26. WolterN

SmithAM

FarrellDJ

SchaffnerW

MooreM

2005 Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob Agents Chemother 49 3554 3557

27. TohSM

XiongL

AriasCA

VillegasMV

LolansK

2007 Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol Microbiol 64 1506 1514

28. MendesRE

DeshpandeLM

CastanheiraM

DipersioJ

SaubolleM

2008 First Report of cfr-mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States. Antimicrob Agents Chemother 52 2244 2246

29. RobertsMC

2008 Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol Lett 282 147 159

30. HowdenBP

SmithDJ

MansellA

JohnsonPD

WardPB

2008 Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. BMC Microbiol 8 39

31. MoisanH

BrouilletteE

JacobCL

Langlois-BeginP

MichaudS

2006 Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J Bacteriol 188 64 76

32. HironA

Borezee-DurantE

PiardJC

JuillardV

2007 Only one of four oligopeptide transport systems mediates nitrogen nutrition in Staphylococcus aureus. J Bacteriol 189 5119 5129

33. HighlanderSK

HultenKG

QinX

JiangH

YerrapragadaS

2007 Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol 7 99

34. Aubry-DamonH

SoussyCJ

CourvalinP

1998 Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 42 2590 2594

35. FerreroL

CameronB

CrouzetJ

1995 Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother 39 1554 1558

36. TohSM

XiongL

BaeT

MankinAS

2008 The methyltransferase YfgB/RlmN is responsible for modification of adenosine 2503 in 23S rRNA. Rna 14 98 106

37. PillaiSK

SakoulasG

WennerstenC

EliopoulosGM

MoelleringRCJr

2002 Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis 186 1603 1607

38. MekaVG

PillaiSK

SakoulasG

WennerstenC

VenkataramanL

2004 Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J Infect Dis 190 311 317

39. BaeT

SchneewindO

2006 Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55 58 63

40. HoggT

MecholdU

MalkeH

CashelM

HilgenfeldR

2004 Conformational antagonism between opposing active sites in a bifunctional RelA/SpoT homolog modulates (p)ppGpp metabolism during the stringent response [corrected]. Cell 117 57 68

41. SabinaJ

DoverN

TempletonLJ

SmulskiDR

SollD

2003 Interfering with different steps of protein synthesis explored by transcriptional profiling of Escherichia coli K-12. J Bacteriol 185 6158 6170

42. RheeHW

LeeCR

ChoSH

SongMR

CashelM

2008 Selective fluorescent chemosensor for the bacterial alarmone (p)ppGpp. J Am Chem Soc 130 784 785

43. Haslinger-LofflerB

KahlBC

GrundmeierM

StrangfeldK

WagnerB

2005 Multiple virulence factors are required for Staphylococcus aureus-induced apoptosis in endothelial cells. Cell Microbiol 7 1087 1097

44. PelegAY

MongaD

PillaiS

MylonakisE

MoelleringRCJr

2009 Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis 199 532 536

45. MwangiMM

WuSW

ZhouY

SieradzkiK

de LencastreH

2007 Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A 104 9451 9456

46. YoshidaK

ShojiH

HanakiH

YanagisawaC

Ikeda-DantsujiY

2009 Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid. J Infect Chemother 15 417 419

47. HillRL

KearnsAM

NashJ

NorthSE

PikeR

2010 Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients. J Antimicrob Chemother 65 442 445

48. WongA

ReddySP

SmythDS

Aguero-RosenfeldME

SakoulasG

2010 Polyphyletic emergence of linezolid-resistant staphylococci in the United States. Antimicrob Agents Chemother 54 742 748

49. LockeJB

HilgersM

ShawKJ

2009 Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin. Antimicrob Agents Chemother 53 5275 5278

50. KehrenbergC

SchwarzS

JacobsenL

HansenLH

VesterB

2005 A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol 57 1064 1073

51. LongKS

PoehlsgaardJ

KehrenbergC

SchwarzS

VesterB

2006 The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics. Antimicrob Agents Chemother 50 2500 2505

52. FengJ

LupienA

GingrasH

WasserscheidJ

DewarK

2009 Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance. Genome Res 19 1214 1223

53. AriasCA

VallejoM

ReyesJ

PanessoD

MorenoJ

2008 Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase. J Clin Microbiol 46 892 896

54. KehrenbergC

CunyC

StrommengerB

SchwarzS

WitteW

2009 Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr. Antimicrob Agents Chemother 53 779 781

55. LannergardJ

von EiffC

SanderG

CordesT

SeggewissJ

2008 Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus. Antimicrob Agents Chemother 52 4017 4022

56. ChatterjeeI

KriegeskorteA

FischerA

DeiwickS

TheimannN

2008 In vivo mutations of thymidylate synthase (encoded by thyA) are responsible for thymidine dependency in clinical small-colony variants of Staphylococcus aureus. J Bacteriol 190 834 842

57. SchaaffF

BierbaumG

BaumertN

BartmannP

SahlHG

2003 Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. Int J Med Microbiol 293 427 435

58. KohlerC

von EiffC

PetersG

ProctorRA

HeckerM

2003 Physiological characterization of a heme-deficient mutant of Staphylococcus aureus by a proteomic approach. J Bacteriol 185 6928 6937

59. von EiffC

McNamaraP

BeckerK

BatesD

LeiXH

2006 Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J Bacteriol 188 687 693

60. O'RiordanK

LeeJC

2004 Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 17 218 234

61. CLSI

2009 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard—seventh edition, CLSI document M7-A8

62. HowdenBP

JohnsonPD

WardPB

StinearTP

DaviesJK

2006 Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 50 3039 3047

63. HowdenBP

StinearTP

AllenDL

JohnsonPD

WardPB

2008 Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus. Antimicrob Agents Chemother 52 3755 3762

64. EnrightMC

RobinsonDA

RandleG

FeilEJ

GrundmannH

2002 The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 99 7687 7692

65. van de RijnI

KesslerRE

1980 Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun 27 444 448

66. SaalLH

TroeinC

Vallon-ChristerssonJ

GruvbergerS

BorgA

2002 BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 15 8

67. SmythGK

2004 Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3 Article 3

68. ZerbinoDR

BirneyE

2008 Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18 821 829

69. SambrookJ

FritschEF

ManiatisT

1989 Molecular cloning: a laboratory manual: Cold Springs Harbor, NY Cold Springs Harbor Laboratory Press

70. TatusovRL

FedorovaND

JacksonJD

JacobsAR

KiryutinB

2003 The COG database: an updated version includes eukaryotes. BMC Bioinformatics 4 41

71. KreiswirthBN

LofdahlS

BetleyMJ

O'ReillyM

SchlievertPM

1983 The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305 709 712

72. WannER

DassyB

FournierJM

FosterTJ

1999 Genetic analysis of the cap5 locus of Staphylococcus aureus. FEMS Microbiol Lett 170 97 103

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 6
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa